FI81093C - NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. - Google Patents
NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. Download PDFInfo
- Publication number
- FI81093C FI81093C FI882241A FI882241A FI81093C FI 81093 C FI81093 C FI 81093C FI 882241 A FI882241 A FI 882241A FI 882241 A FI882241 A FI 882241A FI 81093 C FI81093 C FI 81093C
- Authority
- FI
- Finland
- Prior art keywords
- inden
- dihydro
- imidazole derivatives
- nya
- oxi
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
8109381093
Uusia välituotteina käyttökelpoisia 4(5)-(2,3-dihydro-l-oksi-lH-inden-2-yyli)-imidatsolijohdannaisia - Nya som raellanprodukter användbara 4(5)-(2,3-dihydro-l-oxi-lH-inden-2-yl)-imidazolderivatNew 4 (5) - (2,3-dihydro-1-oxy-1H-inden-2-yl) -imidazole derivatives useful as intermediates - Nya som raellanprodukter användbara 4 (5) - (2,3-dihydro-1-oxy- H-inden-2-yl) -imidazolderivat
Jakamalla erotettu hakemuksesta 854335 - Avdelad frän ansökan 854335 Tämä keksintö koskee uusia välituotteita terapeuttisesti arvokkaiden 4(5)-substituoitujen imidatsolijohdannaisten sekä niiden myrkyttömien suolojen valmistuksessa.This invention relates to novel intermediates in the preparation of therapeutically valuable 4 (5) -substituted imidazole derivatives and their non-toxic salts.
Kantahakemuksen FI 854335 mukaiset imidatsolijohdannaiset ovat uusia tehokkaita ja selektiivisiä a2-reseptorianta-gonisteja joiden yleinen kaava on r.3 ?2 R1 r4 ά jossa X on -CH2- , -CH2CH2- tai -O-, on H tai 1-4 hiiliatomia sisältävä alempi alkyyliryhmä, R2 on H, CH3, CH2CH3, OCH3 tai OH, R3 on H, CH3, CH2CH3, OCH3 tai Hai, R4 on H, CH3, CH2CH3, OCH3 tai Hai ja Hai on halogeeni.The imidazole derivatives according to the basic application FI 854335 are new potent and selective α2-receptor antagonists of the general formula r.3? 2 R1 r4 ά wherein X is -CH2-, -CH2CH2- or -O-, is H or contains 1-4 carbon atoms. lower alkyl, R 2 is H, CH 3, CH 2 CH 3, OCH 3 or OH, R 3 is H, CH 3, CH 2 CH 3, OCH 3 or Hal, R 4 is H, CH 3, CH 2 CH 3, OCH 3 or Hal and Hal is halogen.
Kaavan (I) mukaiset yhdisteet, joissa R2 on H tai OH ja XCompounds of formula (I) wherein R 2 is H or OH and X is
on -CH2-, voidaan esimerkiksi valmistaa seuraavalla menetelmällä: 2 81093 <*3 j? »1 «3 R1 0 'V-v. // halogenointi S^' y\ / H-C-NH2 R4 0 R4 0 R3 0 RX R3 OH Rl 0./\ / NaBH4 X. —V // "<lT> ./ ^-x I!is -CH2-, can be prepared, for example, by the following method: 2 81093 <* 3 j? »1« 3 R1 0 'V-v. // halogenation S ^ 'y \ / H-C-NH2 R4 0 R4 0 R3 0 RX R3 OH R10 0 ./ \ / NaBH4 X. —V // "<lT> ./ ^ -x I!
H AH A
γβ H2, Pd/C H2 Pd/C, }β ' /γβ H2, Pd / C H2 Pd / C,} β '/
R3 M XR3 M X
.//r>κ IL/.//r>κ IL /
AA
Välituotteet, joiden kaava on R3 0 Ri ϊι>^τ> R4''^ -nIntermediates of formula R3 0 Ri ϊι> ^ τ> R4 '' ^ -n
HB
jossa R^t R3 ja R4 merkitsevät samaa kuin yllä, ovat uusia.wherein R 1, R 3 and R 4 are as defined above are new.
Esimerkeissä, joissa on esitetty ^-H-NMR-spektrometriset siirtymät, NMR-spektrit on otettu Bruker WB 80 I)S-laitteella sisäistä tetrametyylisilaanistandardia käyttäen, jostaIn the examples showing 1 H-NMR spectrometric shifts, the NMR spectra were taken on a Bruker WB 80 I) S instrument using an internal tetramethylsilane standard from which
IIII
3 81093 esitetyt kemialliset siirtymät (6, ppm) on taulukoitu. Kirjaimin s, d, t ja m on ilmoitettu, onko kysymyksessä singletti, dubletti, tripletti vai multipletti. Samaan yhteyteen on niin ikään merkitty vetyatomien lukumäärä.The chemical shifts (6, ppm) shown in 3,81093 are tabulated. The letters s, d, t and m indicate whether it is a singlet, a doublet, a triplet or a multiplet. The number of hydrogen atoms is also indicated in the same context.
Esimerkki 1 4(5)-(2,3-Dihydro-2-etyyli-l-hydroksi-lH-inden-2-yyli)imi-datsoli a) 4(5)-(2,3-Dihydro-2-etyyli-l-okso-lH-inden-2-yyli)imi-datsoli 2-Asetyyli-l-indanoni (Liebigs Ann. Chem. 347 (1906) 112) alkyloidaan etyylibromidilla asetonissa natriumkarbonaatin läsnäollessa, jolloin saadaan 2-asetyyli-2-etyyli-l-inda-nonia. 2.2 g 2-asetyyli-2-etyyli-l-indanonia liuotetaan 10 ml:aan metanolia. Lisätään nopeasti bromi (1.60 g) metanoliin (2 ml) liuotettuna 40-50°C:ssa. Reaktio seurataan kaasukromatograafisesti. Reaktion mentyä lisätään vettä. Tuote uutetaan tolueeniin, ja tolueeniliuos pestään 10% Na2C03-liuoksella ja lopuksi vedellä. Tolueeniliuos kuivataan ja haihdutetaan. 2-bromi-l-(2-etyyli-2,3-dihydro- l-okso-lH-inden-2-yyli)etanonin (2.2 g) ja formamidin (20 ml) seosta kuumennetaan l30-140°C:ssa yksi vuorokausi.Example 1 4 (5) - (2,3-Dihydro-2-ethyl-1-hydroxy-1H-inden-2-yl) imidazole a) 4 (5) - (2,3-Dihydro-2-ethyl -1-Oxo-1H-inden-2-yl) imidazole 2-Acetyl-1-indanone (Liebigs Ann. Chem. 347 (1906) 112) is alkylated with ethyl bromide in acetone in the presence of sodium carbonate to give 2-acetyl-2-ethyl -L-inda-fluoroacetophenone. 2.2 g of 2-acetyl-2-ethyl-1-indanone are dissolved in 10 ml of methanol. Bromine (1.60 g) dissolved in methanol (2 ml) is rapidly added at 40-50 ° C. The reaction is monitored by gas chromatography. After the reaction, water is added. The product is extracted into toluene and the toluene solution is washed with 10% Na2CO3 solution and finally with water. The toluene solution is dried and evaporated. A mixture of 2-bromo-1- (2-ethyl-2,3-dihydro-1-oxo-1H-inden-2-yl) ethanone (2.2 g) and formamide (20 ml) is heated at 130-140 ° C for one day.
Seos jäähdytetään, kaadetaan veteen ja tehdään happamaksi suolahapolla. Hapan liuos pestään tolueenilla. Sen jälkeen vesiliuos tehdään emäksiseksi ja tuote uutetaan metyleenikloridiin. Metyleenikloridiliuos pestään vedellä, kuivataan ja haihdutetaan kuiviin. Tuote kiteytetään emäksenä etyyliasetaatista, sp. 126-7°C.The mixture is cooled, poured into water and acidified with hydrochloric acid. The acidic solution is washed with toluene. The aqueous solution is then basified and the product is extracted into methylene chloride. The methylene chloride solution is washed with water, dried and evaporated to dryness. The product is crystallized as a base from ethyl acetate, m.p. 126-7 ° C.
b) 4(5)-(2,3-Dihydro-2-etyyli-l-hydroksi-lH-inden-2-yyli)-imidatsolib) 4- (S) - (2,3-Dihydro-2-ethyl-1-hydroxy-1H-inden-2-yl) -imidazole
Okso-indeeni-imidatsolin (vaihe a) karbonyyliryhmä pelkistetään NaBH^sllä etanolissa alkoholiryhmäksi. Tuote on 4 81093 cis-transstereoisomeerien seos, ja sen puhdistus suoritetaan nestekromatograafisesti.The carbonyl group of the oxoindene imidazole (step a) is reduced with NaBH 4 in ethanol to the alcohol group. The product is a mixture of 4,81093 cis-transstereoisomers and is purified by liquid chromatography.
cis-isomeeri hydrokloridina (s.p. 184-185°C): !h NMR (80 MHz, MeOH-d4): 6 0.73 (3H t), 1.86 (2H, m), 3.36 (2H, m), 3.61 (3H, s), 5.15 (1H, s), 7.06 (1H, d), 7.2-7.4 (4H, m), 8.69 (1H, d) trans-isomeeri hydrokloridinas *H NMR (80 MHz, MeOH-d4): 8 0.80 (3H, t), 1.84 (2H, m), 3.15 (2H, m), 3.24 (3H, s), 5.15 (1H, s), 6.87 (1H, d), 7.2-7.4 (4H, m), 8.54 (1H, d)cis-isomer as hydrochloride (mp 184-185 ° C): 1 H NMR (80 MHz, MeOH-d 4): δ 0.73 (3H t), 1.86 (2H, m), 3.36 (2H, m), 3.61 (3H, s), 5.15 (1H, s), 7.06 (1H, d), 7.2-7.4 (4H, m), 8.69 (1H, d) trans-isomer in hydrochloride 1 H NMR (80 MHz, MeOH-d 4): δ 0.80 (3H, t), 1.84 (2H, m), 3.15 (2H, m), 3.24 (3H, s), 5.15 (1H, s), 6.87 (1H, d), 7.2-7.4 (4H, m), 8.54 (1 H, d)
Esimerkki 2 4(5)-(2,3-Dihydro-2-etyyli-lH-inden-2-yyli)-imidatsoliExample 2 4 (S) - (2,3-Dihydro-2-ethyl-1H-inden-2-yl) -imidazole
Esimerkin 1 vaiheen a) mukaisesti valmistettu okso-johdannainen tai vaiheen b) mukaisesti valmistettu hydroksi-johdannainen vedytetään 2N HClsssä lämpötilassa 70°C käyttäen 10 % Pd/C katalyyttinä. Kun vedyn kulutus loppuu, reaktioseos suodatetaan ja tehdään alkaaliseksi. Tuote uutetaan metyleenikloridilla, joka pestään vedellä, kuivataan ja haihdutetaan. Lopputuotteesta, joka on tuotteen emäsmuoto, tehdään hydrokloridi etyyliasetaatissa kuivalla HC1:llä. S.p. 2ll-215°C.The oxo derivative prepared according to step a) of Example 1 or the hydroxy derivative prepared according to step b) is hydrogenated in 2N HCl at 70 ° C using 10% Pd / C as a catalyst. When the consumption of hydrogen ceases, the reaction mixture is filtered and made alkaline. The product is extracted with methylene chloride, which is washed with water, dried and evaporated. The final product, which is the base form of the product, is converted to the hydrochloride in ethyl acetate with dry HCl. Mp 2LL-215 ° C.
ilil
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8429578 | 1984-11-23 | ||
GB08429578A GB2167408B (en) | 1984-11-23 | 1984-11-23 | Substituted imidazole derivatives and their preparation and use |
FI854335A FI80264C (en) | 1984-11-23 | 1985-11-05 | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA IMIDAZOLDERIVAT, SOM AER SUBSTITUERADE MED EN BISYKLISK GRUPP I 4 (5) -STAELLNING. |
FI854335 | 1985-11-05 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI882241A FI882241A (en) | 1988-05-13 |
FI882241A0 FI882241A0 (en) | 1988-05-13 |
FI81093B FI81093B (en) | 1990-05-31 |
FI81093C true FI81093C (en) | 1990-09-10 |
Family
ID=26157830
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI882241A FI81093C (en) | 1984-11-23 | 1988-05-13 | NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. |
FI882242A FI80880C (en) | 1984-11-23 | 1988-05-13 | New 4 (5) -substituted imidazole derivatives useful as intermediates |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI882242A FI80880C (en) | 1984-11-23 | 1988-05-13 | New 4 (5) -substituted imidazole derivatives useful as intermediates |
Country Status (1)
Country | Link |
---|---|
FI (2) | FI81093C (en) |
-
1988
- 1988-05-13 FI FI882241A patent/FI81093C/en not_active IP Right Cessation
- 1988-05-13 FI FI882242A patent/FI80880C/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI80880C (en) | 1990-08-10 |
FI882241A (en) | 1988-05-13 |
FI882242A0 (en) | 1988-05-13 |
FI882241A0 (en) | 1988-05-13 |
FI80880B (en) | 1990-04-30 |
FI882242A (en) | 1988-05-13 |
FI81093B (en) | 1990-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4113869A (en) | Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them | |
FI63229C (en) | FREQUENCY REFRIGERATION OF ANALYTICAL NETWORK RACEMISKT ELLER DIASTEREOMERA AND OPTICAL ACTIVE 2-TETRAHYDROFURFURYL-5,9 BETA-DIMETHYL-6,7-BENZENORORFAN OCH DERAS SYRAADDITION | |
IE62244B1 (en) | 4H-1-benzopyran-4-one derivatives, a process for their preparation and their use as medicaments | |
DK158307B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 4- (PHENYLALKYL) IMIDAZOLD DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF | |
US4665188A (en) | Certain [(1-imidazolyl)-lower-alkylene]-tetrahydronaphthalenecarboxylic acids or corresponding idan-carboxylic acids which are thromboxane A2 | |
CZ284256B6 (en) | Novel process for preparing formoterol and related compounds | |
FI86175B (en) | FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA FENOLDERIVAT. | |
EP0130833A1 (en) | Coumarin compounds, their preparation, and pharmaceutical compositions containing them | |
FI92824C (en) | Process for the preparation of therapeutically useful chromane derivatives | |
US4336268A (en) | Cyclohexene derivative analgesics | |
FI81093C (en) | NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. | |
Lee et al. | Chiral acetylenic sulfoxide in alkaloid synthesis. Total synthesis of (R)-(+)-carnegine. | |
US4181666A (en) | Process for making furanones | |
FI67851C (en) | FAR OIL FRAMSTAELLNING AV NYA DOPAMINAGONISTISKT VERKANDE BENSO (4,5) PYRANO (2,3C) PYRROLDERIVAT | |
FI79100C (en) | Isoquinoline derivatives and process for their preparation. | |
US4411907A (en) | Antiinflammatory 3H-naphtho(1,2-d)imidazoles | |
US4238612A (en) | Process for the isomerization of derivatives of 3-vinyl-piperidine | |
US4751298A (en) | Production of 1-(3-hydroxy-propyl)-1,4-diazepane and 1,4-bis(3,4,5-trimethoxy-benzoyloxy)-propyl-diazepane derivatives thereof | |
US3798225A (en) | 3(2h)-isoquinolones | |
FI61694C (en) | FRAMEWORK FOR FRAMSTERING OF SUBSTITUTES WITH A BLOOD TRYCKET WITH A SHORT-BASED SAFETY NETWORK | |
EP0110496B1 (en) | Improvements in keto intermediates, their use and preparation | |
Cozzi et al. | Imidazolyl derivatives of the chroman ring. 1 | |
US4528372A (en) | N-Phthalidyl-5-fluorouracils | |
EP0379935A1 (en) | A process for preparing naphthalene derivatives | |
US4015006A (en) | 3(2H)-Isoquinolones therapeutic process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: FARMOS-YHTYMAE OY |